On June 6, 2017, Bio-Rad launched a RT-PCR kit that allows researchers to simultaneously screen samples for Zika, dengue, and chikungunya arbovirus RNAs. The assay comes with the controls researchers need to internally validate the results. According to the company , this assay is approved foOriginal Article
You may also like
Ariane de Ganck
Jasper Therapeutics merges with Kira Pharmaceuticals
Lilly to acquire AtaiBeckley in deal worth $2.8bn
Camena Bioscience appoints Gregory McGuinness as CEO
New €25 Million BioReliance Testing Facility Opens...
StockWatch: Lilly’s Up-to-$3.8B Deal for AtaiBeckley...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.
